Form 8-K - Current report:
SEC Accession No. 0001193125-23-127227
Filing Date
2023-04-28
Accepted
2023-04-28 16:34:30
Documents
14
Period of Report
2023-04-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d475493d8k.htm   iXBRL 8-K 33415
2 EX-3.1 d475493dex31.htm EX-3.1 7277
3 EX-99.1 d475493dex991.htm EX-99.1 10734
  Complete submission text file 0001193125-23-127227.txt   187182

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20230427.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20230427_lab.xml EX-101.LAB 18740
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20230427_pre.xml EX-101.PRE 11726
8 EXTRACTED XBRL INSTANCE DOCUMENT d475493d8k_htm.xml XML 3596
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 23867179
SIC: 3841 Surgical & Medical Instruments & Apparatus